{
   "data": [
      {
         "claim": "Can masks reduce corona infections when worn by a large proportion of the population?",
         "label": 0,
         "prediction": 1,
         "rationale": " Wearing masks helps reduce COVID-19 infections in a population by slowing the spread of the virus, as masks act as a barrier that can prevent respiratory droplets containing the virus from being released into the air when a person talks, coughs, or sneezes.  According to the information provided, yes, wearing masks offers protection against coronavirus for both the wearer and others. Masks act as barriers for respiratory droplets, helping to protect people near the wearer, and studies show that masks provide some level of protection to the wearer as well. The CDC also stresses the importance of wearing masks.  According to the Centers for Disease Control and Prevention (CDC), while any mask is more effective than no mask at reducing the transmission of coronavirus, the organization recommends using the most protective mask that fits well and is comfortable for regular use, without specifying a particular type of mask as the most effective. The CDC's guidance suggests that different masks may offer varying levels of protection. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": " How does wearing masks help reduce corona infections in a population?",
               "answer": "Wearing masks helps reduce COVID-19 infections in a population by slowing the spread of the virus. Masks act as a barrier that can prevent respiratory droplets, which may contain the virus, from being released into the air when a person talks, coughs, or sneezes. This is particularly effective when combined with other",
               "rationale": "1. Yes. When used with measures such as getting vaccinated, hand-washing and physical distancing, wearing a face mask slows how quickly the virus that causes COVID-19 spreads. The U.S. Centers for Disease Control and Prevention (CDC) recommends wearing masks if you choose to, and in specific places and situations.\n2. children or people with certain disabilities who may find it hard to wear a mask; washing and storing reusable masks. The bottom line. The best available evidence shows that mask-wearing can help reduce spread of COVID-19 infections, keep waves of serious illness from overburdening our hospitals, and save lives — possibly even yours.\n3. Abstract. This rapid systematic review of evidence asks whether (i) wearing a face mask, (ii) one type of mask over another and (iii) mandatory mask policies can reduce the transmission of SARS-CoV-2 infection, either in community-based or healthcare settings. A search of studies published 1 January 2020-27 January 2023 yielded 5185 unique ...\n4. In one simulation, researchers predicted that 80 percent of the population wearing masks would do more to reduce COVID-19 spread than a strict lockdown. The latest forecast from the Institute of Health Metrics and Evaluation suggests that 33,000 deaths could be avoided by October 1 if 95 percent of people wore masks in public.\n5. \"The spread of the virus really goes down in areas where people wear masks and it goes as down as four-to-five times reduced risk of infection when people in the community are wearing a mask ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": " Does wearing masks provide protection against coronavirus for the wearer as well as others?",
               "answer": "Yes, wearing masks provides protection against coronavirus for both the wearer and others. Evidence indicates that masks act as barriers for respiratory droplets, helping to protect those around the wearer. Additionally, studies show that masks, including simple cotton ones, offer some level of protection to the wearer as well. The CDC also emphasizes that wearing a",
               "rationale": "1. A study from Tokyo tested how well different types of masks protected the wearer from actual coronavirus particles. The study showed that even a simple cotton mask offered some protection (17 ...\n2. In areas that have many people with COVID-19 in the hospital, the CDC recommends wearing a face mask indoors in public. The CDC says that you should wear the most protective mask that you'll wear regularly, fits well and is comfortable. Respirators such as nonsurgical N95s give the most protection. KN95s and medical masks provide the next ...\n3. Mask-wearing helps protect against illness from viruses that travel through the air — not just COVID-19, but also colds and flu. Some people worry that masks trap carbon dioxide (CO 2) or limit the amount of oxygen you inhale, but that's not true. As you breathe out in a mask, C0 2 escapes; as you breathe in, you receive oxygen.\n4. A: A face mask provides protection to those around you, as well as yourself. Face masks act as barriers for respiratory droplets. Whether you're coughing and the droplets catch in the inside of ...\n5. The CDC says that when it comes to cloth masks, multiple layers made of higher thread counts do a better job of protecting the wearer. Wearing a mask protects the wearer, and not just other people ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": " Is there a specific type of mask that is most effective at reducing the transmission of coronavirus?",
               "answer": "The evidence suggests that while any mask is better than no mask, the CDC recommends wearing the most protective mask that fits well and is comfortable for regular use. However, it does not specify a single type of mask as the most effective. Instead, it implies that different types of masks may have varying levels of effectiveness, and",
               "rationale": "1. CDC has updated our consumer webpage describing the types of masks and respirators used to prevent the transmission of SARS-CoV-2. Masking is a critical public health tool to prevent the spread of COVID-19, and it is important to remember that any mask is better than no mask.\n2. The U.S. Centers for Disease Control and Prevention (CDC) recommends wearing masks if you choose to, and in specific places and situations. In areas that have many people with COVID-19 in the hospital, the CDC recommends wearing a face mask indoors in public.. The CDC says that you should wear the most protective mask that you'll wear regularly, fits well and is comfortable.\n3. This rapid systematic review of evidence asks whether (i) wearing a face mask, (ii) one type of mask over another and (iii) mandatory mask policies can reduce the transmission of SARS-CoV-2 infection, either in community-based or healthcare settings. A search of studies published 1 January 2020-27 January 2023 yielded 5185 unique records.\n4. Dentists and dental hygienists sometimes wear them when working close to patients' mouths. Doctors, nurses and technologists might use face shields, together with face masks, when performing procedures that could propel blood or other substances into the air. You should not wear a face shield in place of a mask or wear clear shield-like face ...\n5. Face masks are a simple way to help decrease coronavirus transmission and save lives. According to the Centers for Disease Control and Prevention, wearing a face mask in public places has been shown to reduce the spread of COVID-19, because those who are pre-symptomatic can spread the virus before showing symptoms.",
               "predicate": null
            }
         ],
         "row": 0,
         "id": 895888100905599995
      },
      {
         "claim": "Does paxlovid protect unvaccinated people with risk factors from severe or even fatal covid 19 disease?",
         "label": 0,
         "prediction": 1,
         "rationale": " Paxlovid is a medication claimed to protect against severe disease from COVID-19, focusing on individuals at high risk, such as older adults and those who are immunocompromised. It is effective in decreasing the risk of hospitalization or death, regardless of a person's vaccination status.  Yes, Paxlovid is an oral antiviral medication, and the clinical trial results showed a lower hospitalization rate in high-risk patients treated with Paxlovid compared to the placebo group; however, it should be used in conjunction with other preventative measures and does not replace vaccination.  Paxlovid has received emergency use authorization from the FDA for treating COVID-19.  Paxlovid has received Emergency Use Authorization (EUA) from the FDA for treating COVID-19 in pediatric patients who are 12 years of age and older and weigh at least 40 kg, and who are at risk for progression to severe illness.  Paxlovid is available by prescription only, as the provided answer states. The question asked about individuals at high risk for severe COVID-19 and mentioned certain medical conditions, but the answer does not provide any information about this topic, so it should not be included in the statement. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": " What is Paxlovid claimed to protect, in terms of COVID-19 severity and vaccination status?",
               "answer": "Paxlovid is claimed to protect against severe disease from COVID-19, particularly for individuals at high risk, such as older adults and those who are immunocompromised. It is effective in reducing the risk of hospitalization or death, regardless of vaccination status. Specifically, the evidence indicates that only 0.8",
               "rationale": "1. Paxlovid, an oral antiviral pill that can be taken at home, is the go-to treatment for COVID-19. If you are at high risk for severe disease from COVID, and you take it within the first five days of experiencing symptoms, it will lower your risk of getting so sick that you need to be hospitalized. Paxlovid is available to anyone ages 12 and up ...\n2. A Pfizer-led study supports the benefits of Paxlovid in COVID-19 patients who are at high risk for severe or prolonged disease, particularly older adults and those who are immunocompromised. ... Only 0.8% of those who took Paxlovid (regardless of vaccination status) were hospitalized or died compared to 1.6% of patients who received the placebo ...\n3. Paxlovid was 89% effective at reducing the risk of hospitalization or death, according to data from the clinical trial that led to the drug's Emergency Use Authorization. These results were among 1,219 people ages 18 and older who were given Paxlovid within 3 days of experiencing COVID-19 symptoms. Paxlovid is still being studied, though.\n4. Among the 1,039 patients who took a five-day course of Paxlovid within five days of developing symptoms, eight, or 0.8%, were hospitalized for COVID-19 or died from any cause after 28 days of ...\n5. How does Paxlovid work? \"Paxlovid is a class of antiviral drug called a protease inhibitor,\" explains Adalja. It prevents the SARS-CoV-2 virus, which causes COVID-19 infection, from replicating in the body. At a molecular level, \"Paxlovid works by disrupting the protein cutting process of SARS-CoV-2,\" he explains.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": " ...percent of high-risk patients treated with Paxlovid were hospitalized due to COVID-19, compared to 6.3 percent in the placebo group. However, it is important to note that Paxlovid is not a substitute for vaccination and should be used in conjunction with other preventative measures. Now, is Paxlovid an oral antiviral medication?",
               "answer": "Yes, Paxlovid is an oral antiviral medication.",
               "rationale": "1. In this analysis, 977 patients received Paxlovid, and 989 patients received placebo, and among these patients, 0.9% who received Paxlovid were hospitalized due to COVID-19 or died from any cause ...\n2. Paxlovid is an oral antiviral medication that received Emergency Use Authorization by the Food and Drug Administration ... for use in patients with mild-to-moderate COVID-19 at high risk for progression to severe ... (0.47%) were hospitalized, §§§§ compared with 4,299 (0.86%) of nonrecipients. Among the 5,229 persons with a COVID-19 ...\n3. Paxlovid, an oral antiviral pill that can be taken at home, is the go-to treatment for COVID-19. If you are at high risk for severe disease from COVID, and you take it within the first five days of experiencing symptoms, it will lower your risk of getting so sick that you need to be hospitalized. Paxlovid is available to anyone ages 12 and up ...\n4. Dr. John Farley. Paxlovid is now widely available in community pharmacies. Although the number of COVID-19 hospitalizations has decreased dramatically since early 2022, some high-risk patients are ...\n5. PAXLOVID is the first FDA-approved oral treatment for COVID-19; has been authorized for emergency use since December 2021 Approval is based on the totality of scientific evidence submitted, including efficacy data from the Phase 2/3 EPIC-HR study showing an 86% reduction in risk of COVID-19-related hospitalization or death from any cause in patients who took PAXLOVID within five days of ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": " Has Paxlovid received emergency use authorization from the FDA for treating COVID-19?",
               "answer": "Yes, Paxlovid has received emergency use authorization from the FDA for treating COVID-19.",
               "rationale": "1. In May 2023, FDA approved Pfizer's new drug application (NDA) for Paxlovid for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19 ...\n2. The FDA approved Paxlovid for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19.\n3. PAXLOVID is the first FDA-approved oral treatment for COVID-19; has been authorized for emergency use since December 2021 Approval is based on the totality of scientific evidence submitted, including efficacy data from the Phase 2/3 EPIC-HR study showing an 86% reduction in risk of COVID-19-related hospitalization or death from any cause in patients who took PAXLOVID within five days of ...\n4. Today, the FDA issued an emergency use authorization for the first oral antiviral for treatment of COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 ...\n5. NEW YORK, December 22, 2021 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg [88 lbs]) with positive results of ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": " For which age groups and risk levels has Paxlovid received emergency use authorization from the FDA for treating COVID-19?",
               "answer": "Paxlovid has received Emergency Use Authorization (EUA) from the FDA for treating COVID-19 in the following age groups and risk levels:\n\n1. **Age Group**: Pediatric patients 12 years of age and older (weighing at least 40 kg).\n2. **Risk Level**: Patients",
               "rationale": "1. [01/29/2024] In December 2021, FDA authorized Paxlovid for emergency use for the treatment of adults and pediatric patients (12 years of age and older weighing at least 40 kg) who are at high risk ...\n2. The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the emergency use of PAXLOVID for the treatment of pediatric patients 12 years of age and older\n3. The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to make PAXLOVID available for the treatment of mild-to-moderate COVID-19 in children 12 years of age ...\n4. The Food and Drug Administration (FDA) gave the drug full approval in May 2023 for adults with mild-to-moderate COVID at high risk for severe disease, hospitalization, and death. This was after the administration initially granted an Emergency Use Authorization (EUA) in December 2021 for everyone 12 and older (weighing at least 88 pounds).\n5. The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the emergency use of PAXLOVID for the treatment of adults and pediatric patients (12 years of age and older weighing at least 40 kg) with mild to moderate coronavirus disease 2019 (COVID-19) and who are at high risk for progression to severe",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": " ...who are at high risk for progression to severe COVID-19, including those who are 65 years of age or older or who have certain medical conditions, such as weakened immune systems, chronic kidney disease, diabetes, or obesity. Now, is Paxlovid available by prescription only?",
               "answer": "Yes, Paxlovid is available by prescription only.",
               "rationale": "1. The risk of serious COVID-19 illness also is higher for people who have conditions that damage lung tissue over time. Examples are tuberculosis, cystic fibrosis, interstitial lung disease, bronchiectasis or COPD, which stands for chronic obstructive pulmonary disease. These diseases raise the risk of needing care in the hospital for COVID-19.\n2. Diabetes As a Risk Factor for COVID-19. People who have diabetes are at increased risk of getting very sick from the coronavirus that causes COVID-19. Type 1 and type 2 diabetes both cause an increase in blood sugar. Poorly controlled blood sugar can make viral diseases, including COVID-19, more dangerous, possibly because higher blood sugar ...\n3. Healthcare providers can continue to promote staying up to date with COVID-19 vaccine (getting primary series and boosters) and following preventive measures for COVID-19, especially if a person is older, is immunocompromised, has severe health conditions, or has more than one underlying or high-risk medical condition.\n4. Risk of severe outcomes is increased in people of all ages with certain underlying medical conditions and in people who are 50 years and older, with risk increasing substantially at ages >65 years. 4,5 Residents of long-term care facilities are also at increased risk, making up less than 1% of the U.S. population but accounting for more than 35 ...\n5. Older adults are at highest risk of getting very sick from COVID-19. More than 81% of COVID-19 deaths occur in people over age 65. The number of deaths among people over age 65 is 97 times higher than among people ages 18-29 years. Your risk of severe illness from COVID-19 increases as the number of your underlying medical conditions increase.",
               "predicate": null
            }
         ],
         "row": 1,
         "id": 336210858627457020
      },
      {
         "claim": "Does regular HPV testing in addition to the recommended Pap smear detect more precancerous lesions than just the Pap smear alone?",
         "label": 0,
         "prediction": 1,
         "rationale": " Regular HPV testing, which involves conducting an HPV test in addition to the Pap smear during a pelvic exam, specifically looks for the presence of the HPV virus in the cervical cells collected by a gynecologist for laboratory analysis.  In clinical studies, regular HPV testing in addition to the Pap smear has been found to detect more cases of precancerous lesions compared to just the Pap smear alone, due to its ability to detect more high-grade cervical intraepithelial neoplasia (CIN). Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": " What does regular HPV testing involve in addition to the Pap smear?",
               "answer": "Regular HPV testing involves conducting an HPV test in addition to the Pap smear. Both tests are performed as part of a pelvic exam, where a gynecologist collects cells from the cervix for analysis in a laboratory. The HPV test specifically looks for the presence of the HPV virus in the cervical cells.",
               "rationale": "1. Age 30-64 - Pap test and HPV test every five years. A Pap test can detect abnormalities in the cells of your cervix that are cancer or may become cancer. The HPV test looks for the presence of the HPV virus in your cervix. Almost all cervical dysplasia and cervical cancers are caused by the HPV virus. \"Doing the HPV screening lets us ...\n2. This discovery has led to changes in how women are screened for cervical cancer. Women now get HPV tests in addition to Pap smears. Both tests can be conducted as part of a pelvic exam. Your gynecologist collects cells from the cervix, which are then analyzed in a laboratory. The pelvic exam itself is also an important cancer detection tool.\n3. The Pap test, also called a Pap smear, and the HPV test both look for changes in cells of the cervix that may turn into cancer or make a woman more likely to develop cancer. Both require taking a small sample of cells from the cervix, putting them into a liquid, and then testing the cells. The Pap test was a huge advance in women's health.\n4. Human papillomavirus, also called HPV, that is spread through sexual activity can cause genital warts, changes in cervical cells or cancers. The HPV test looks for evidence of the virus in samples from the body. This test may be done at the same time or after another screening test called a Pap test or Pap smear.\n5. Unsatisfactory Pap test results: The lab sample may not have had enough cells, or the cells may have been clumped together or hidden by blood or mucus. Your health care provider will ask you to come in for another Pap test in 2 to 4 months. Abnormal Pap test results: An abnormal test result may also be called a positive test result.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": " Has it been found that regular HPV testing in addition to the Pap smear detects more cases of precancerous lesions compared to just the Pap smear alone in clinical studies?",
               "answer": "Yes, it has been found that regular HPV testing in addition to the Pap smear detects more cases of precancerous lesions compared to just the Pap smear alone in clinical studies. Evidence from clinical trials indicates that primary hrHPV testing and co-testing (Pap test and HPV test) detect more cases of high-grade cervical intra",
               "rationale": "1. Unsatisfactory Pap test results: The lab sample may not have had enough cells, or the cells may have been clumped together or hidden by blood or mucus. Your health care provider will ask you to come in for another Pap test in 2 to 4 months. Abnormal Pap test results: An abnormal test result may also be called a positive test result.\n2. This discovery has led to changes in how women are screened for cervical cancer. Women now get HPV tests in addition to Pap smears. Both tests can be conducted as part of a pelvic exam. Your gynecologist collects cells from the cervix, which are then analyzed in a laboratory. The pelvic exam itself is also an important cancer detection tool.\n3. The Pap test, also called a Pap smear, and the HPV test both look for changes in cells of the cervix that may turn into cancer or make a woman more likely to develop cancer. Both require taking a small sample of cells from the cervix, putting them into a liquid, and then testing the cells. The Pap test was a huge advance in women's health.\n4. Data from clinical trial, cohort, and modeling studies demonstrate that among average-risk patients aged 25-65 years, primary hrHPV testing and co-testing detect more cases of high-grade cervical intraepithelial neoplasia than cytology alone, but hrHPV-based tests are associated with an increased risk of colposcopies and false-positive ...\n5. Based on solid evidence, screening every 5 years with the Pap test and the HPV DNA test (cotesting) in women aged 30 years and older is more sensitive in detecting cervical abnormalities, compared with the Pap test alone. Screening with the Pap test and HPV DNA test reduces the incidence of cervical cancer. [ 3]",
               "predicate": null
            }
         ],
         "row": 2,
         "id": 601571305545792041
      },
      {
         "claim": "Can monk's pepper reduce PMS symptoms? PMS is the abbreviation for premenstrual syndrome. This refers to complaints that occur in the days before menstruation.",
         "label": 0,
         "prediction": 1,
         "rationale": " Monk's pepper, also known as Vitex agnus-castus, is believed to alleviate certain premenstrual syndrome (PMS) symptoms, including mood swings, irritability, and breast tenderness, by potentially helping to balance hormones and regulate menstrual cycles.  According to the information provided, monk's pepper (Vitex agnus-castus) has a traditional reputation for alleviating certain PMS symptoms, such as mood swings, irritability, and breast tenderness, but there is no explicit mention of specific scientific research confirming its effectiveness in reducing PMS symptoms.  According to the provided information, while monk's pepper, or Vitex agnus castus, has a history of use for addressing female hormonal issues and menstrual symptoms, including PMS, specific scientific studies are needed to validate the claim that monk's pepper reduces PMS symptoms.  Clinical trials have been conducted to test the effectiveness of monk's pepper, also known as Vitex agnus-castus, in alleviating symptoms of premenstrual syndrome (PMS). The results of these studies suggest that monk's pepper may help reduce various PMS symptoms, such as breast pain, irritability, and depressed mood. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": " What is monk's pepper believed to do in relation to PMS symptoms?",
               "answer": "Monk's pepper (Vitex agnus-castus) is believed to help reduce PMS symptoms such as mood swings, irritability, and breast tenderness. It is also thought to promote hormonal balance and regulate menstrual cycles.",
               "rationale": "1. VITEX AGNUS CASTUS AND PMS Vitex agnus castus (medicinal species) or Vitex, agnus castus, chaste tree, chasteberry or Monk's Pepper (common names) is a shrub that originates from the Mediterranean and western Asia. The plant has been used traditionally to relieve symptoms of a number of disorders including those attributed to PMS.\n2. Vitex agnus-castus, also known as chasteberry, chaste tree berry, or monk's pepper, is a small deciduous tree native to the Mediterranean and Western Asia. The fruit (berry) of this tree has traditionally been used for addressing complaints related to female hormones and menstruation. Historically, monks sworn to celibacy would chew on the ...\n3. The word monk brings to mind an enlightened individual, high in the mountains, treading space and time in perfect balance. Monk's pepper (Vitex agnus-castus) offers several facets of this vision, promoting all-around wellness, hormonal balance and skin benefits, as will be detailed later in this article.Monk's pepper is a shrub native to the Mediterranean region and has long been believed ...\n4. Vitex (also called chaste tree berry and monk's pepper) is an herb used for thousands of years in Greece and Italy to promote fertility and balance hormones. It has been shown to be effective in reducing PMS, PMDD symptoms, regulating periods, and normalize cycle length, as well as improving fertility.\n5. Monk's pepper is a versatile supplement that can address a variety of health concerns. Some common uses include: PMS relief: Reducing symptoms such as mood swings, irritability, and breast tenderness. Menstrual cycle regulation: Helping to normalize irregular periods and promote a healthy cycle. Menopause support: Alleviating hot flashes ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": " Has there been any scientific research confirming that monk's pepper can reduce PMS symptoms?",
               "answer": "The provided evidence snippets suggest that monk's pepper (Vitex agnus-castus) has been traditionally used to relieve symptoms associated with premenstrual syndrome (PMS), such as mood swings, irritability, and breast tenderness. However, the snippets do not explicitly mention any specific scientific research or studies confirming the effectiveness of",
               "rationale": "1. The word monk brings to mind an enlightened individual, high in the mountains, treading space and time in perfect balance. Monk's pepper (Vitex agnus-castus) offers several facets of this vision, promoting all-around wellness, hormonal balance and skin benefits, as will be detailed later in this article.Monk's pepper is a shrub native to the Mediterranean region and has long been believed ...\n2. Monk's pepper is a versatile supplement that can address a variety of health concerns. Some common uses include: PMS relief: Reducing symptoms such as mood swings, irritability, and breast tenderness. Menstrual cycle regulation: Helping to normalize irregular periods and promote a healthy cycle. Menopause support: Alleviating hot flashes ...\n3. Introduction. Premenstrual syndrome (PMS) is a common disorder in women of reproductive age and is characterized by at least one physical, emotional, or behavioral symptom, which appears in the luteal phase of the menstrual cycle and resolves shortly after the onset of menses 1.The spectrum of symptoms is wide and the most common are breast tenderness, bloating, headache, mood swings ...\n4. VITEX AGNUS CASTUS AND PMS Vitex agnus castus (medicinal species) or Vitex, agnus castus, chaste tree, chasteberry or Monk's Pepper (common names) is a shrub that originates from the Mediterranean and western Asia. The plant has been used traditionally to relieve symptoms of a number of disorders including those attributed to PMS.\n5. Vitex agnus-castus, also known as chasteberry, chaste tree berry, or monk's pepper, is a small deciduous tree native to the Mediterranean and Western Asia. The fruit (berry) of this tree has traditionally been used for addressing complaints related to female hormones and menstruation. Historically, monks sworn to celibacy would chew on the ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": " monk's pepper in reducing PMS symptoms. To validate the claim, you may need to ask:  Question 3: Can you provide specific scientific studies that show monk's pepper reduces PMS symptoms?",
               "answer": "The provided evidence snippets indicate that Vitex agnus castus, commonly known as monk's pepper, has been traditionally used for addressing complaints related to female hormones and menstruation, including the relief of PMS symptoms. However, to validate the claim that monk's pepper effectively reduces PMS symptoms, specific scientific studies would be required.",
               "rationale": "1. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the effectiveness of Vitex agnus castus for the treatment of PMS symptoms.. We wish to examine the following: (1) The effect of Vitex agnus castus on combined symptoms or global scores associated with PMS versus placebo. (2) The effect of Vitex agnus castus on combined symptoms or global scores ...\n2. Monk's pepper is a versatile supplement that can address a variety of health concerns. Some common uses include: PMS relief: Reducing symptoms such as mood swings, irritability, and breast tenderness. Menstrual cycle regulation: Helping to normalize irregular periods and promote a healthy cycle. Menopause support: Alleviating hot flashes ...\n3. Vitex goes by many names: chasteberry, chaste tree, Abraham's balm, and monk's pepper. The plant is found in Greece, Italy, and parts of the Middle East. We only use the fruit, which is why you'll commonly hear it referred to as \"chaste tree berry.\". Vitex agnus-castus is an herb usually taken in capsule form for premenstrual tension ...\n4. Vitex agnus-castus, also known as chasteberry, chaste tree berry, or monk's pepper, is a small deciduous tree native to the Mediterranean and Western Asia. The fruit (berry) of this tree has traditionally been used for addressing complaints related to female hormones and menstruation. Historically, monks sworn to celibacy would chew on the ...\n5. The dried fruits of the chaste tree Vitex agnus castus (VAC) were traditionally used by monks as a substitute for pepper and was therefore also called Monk's pepper. For the last 50 years it is commercially provided for the treatment of premenstrual symptoms, particularly to prevent premenstrual mastodynia (mastalgia). Most studies were performed with the preparation containing an aqueous ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": " Have any clinical trials been conducted to determine the effectiveness of monk's pepper in alleviating PMS symptoms?",
               "answer": "Yes, clinical trials have been conducted to determine the effectiveness of monk's pepper (Vitex agnus-castus) in alleviating PMS symptoms. The evidence indicates that chasteberry has been studied in clinical trials, where it was found to reduce various PMS symptoms, including breast pain, irritability, depressed mood, and",
               "rationale": "1. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the effectiveness of Vitex agnus castus for the treatment of PMS symptoms.. We wish to examine the following: (1) The effect of Vitex agnus castus on combined symptoms or global scores associated with PMS versus placebo. (2) The effect of Vitex agnus castus on combined symptoms or global scores ...\n2. effects, which may help alleviate mood-related symptoms of PMS. A randomized controlled trial conducted in 2017, aimed to determine the effect of lavender oil aromatherapy on coping with premenstrual syndrome in university students. Data was collected from a total of 73 students by questionnaire form and PMS scale, and the method of\n3. Vitex agnus-castus, also known as chasteberry, chaste tree berry, or monk's pepper, is a small deciduous tree native to the Mediterranean and Western Asia. The fruit (berry) of this tree has traditionally been used for addressing complaints related to female hormones and menstruation. Historically, monks sworn to celibacy would chew on the ...\n4. In clinical trials for the treatment of PMS, chasteberry reduced some symptoms, especially breast pain or tenderness, edema, constipation, irritability, depressed mood, anger, and headache. 4, 14 ...\n5. Many clinical studies were conducted to determine whether red clover could be used to help with menopausal symptoms due to its putative estrogenic activity. A recent (2021) systematic review and meta-analysis by Kanadys et al. presented randomized controlled trials on the use of red clover extract in menopause . The effectiveness of red clover ...",
               "predicate": null
            }
         ],
         "row": 3,
         "id": 119652242776014534
      },
      {
         "claim": "Can probiotics lower blood sugar in type 2 diabetes?",
         "label": 0,
         "prediction": 1,
         "rationale": " Probiotics are known to have the potential to affect blood sugar levels, with some studies suggesting they may slightly decrease HbA1c and fasting insulin levels in individuals with type 2 diabetes. Specifically, a recent randomized controlled trial found that probiotics can help improve glucose spike levels and reduce A1c blood sugar levels.  Yes, clinical trials have studied the effect of probiotics on blood sugar levels specifically in type 2 diabetes patients, with nine randomized controlled trials testing the effects of probiotics on glycemic outcomes in adults with impaired glucose control, including those with type 2 diabetes.  According to the evidence snippet, the specific types of probiotics used in the clinical trials are not detailed, but it is mentioned that \"Lactobacillus,\" a common genus of probiotics, was used in one of the studies. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": " What are probiotics known to do in relation to blood sugar levels?  (This question is aimed at understanding if probiotics have any effect on blood sugar levels before delving into the specific claim about type 2 diabetes.)",
               "answer": "Probiotics are known to have a potential beneficial effect on blood sugar levels. They may slightly decrease HbA1c and fasting insulin levels in individuals with type 2 diabetes. Some studies, including a recent randomized controlled trial, have shown that probiotics can improve glucose spike levels and reduce A1c blood sugar levels.",
               "rationale": "1. Introduction. Probiotics—live microbial communities (microbiota) that may benefit host health (1, 2)—are 1 of the most commonly used nutritional supplements worldwide ().The gut microbiota has been shown to play a role in diabetes—a disease estimated to impact 451 million people in 2017 and projected to impact 693 million by 2045 (3, 4).Several randomized controlled trials (RCTs) have ...\n2. In persons with type 2 diabetes, probiotics only slightly decreased HbA1c and fasting insulin levels. Feizollahzadeh et al. (2017) 40: Lactobacillus plantarum A7: 8: Utilising probiotic soy milk did not decrease inflammation or serum adiponectin; however, it could alter a patient's lipid profile if they had T2DM. Tonucci et al. (2017) 50\n3. A recent double blind, randomized controlled trial breakthrough study was done with the American Diabetes Association, which showed that test subjects with type 2 diabetes who took probiotics for 12 months, vs those who took a placebo: Improved glucose spike levels by 2.5%, and. Improved A1c blood sugar by 0.6%.\n4. Introduction. Probiotics—live microbial communities (microbiota) that may benefit host health (1, 2)—are 1 of the most commonly used nutritional supplements worldwide (3).The gut microbiota has been shown to play a role in diabetes—a disease estimated to impact 451 million people in 2017 and projected to impact 693 million by 2045 (3, 4). ...\n5. With the increasing prevalence of type 2 diabetes mellitus (T2DM), there is increased interest in probiotic supplementation for improving glycaemic control. This review evaluates nine randomized controlled trials that tested the effects of probiotics on glycaemic outcomes including fasting plasma glucose, fasting plasma insulin, haemoglobin A1c ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": " Have there been any clinical trials studying the effect of probiotics on blood sugar levels specifically in type 2 diabetes patients?",
               "answer": "Yes, there have been clinical trials studying the effect of probiotics on blood sugar levels specifically in type 2 diabetes patients. The systematic review mentioned evaluates nine randomized controlled trials that tested the effects of probiotics on glycemic outcomes, including fasting plasma glucose and hemoglobin A1c, in adults with impaired glucose control, including those",
               "rationale": "1. This systematic review aimed to evaluate the effectiveness and safety of probiotics for glycemic control in adults with impaired glucose control, including prediabetes and type 2 diabetes mellitus (T2DM). We searched PubMed, Embase, and Cochrane databases, ...\n2. Abstract With the increasing prevalence of type 2 diabetes mellitus (T2DM), there is increased interest in probiotic supplementation for improving glycaemic control. This review evaluates nine randomized controlled trials that tested the effects of probiotics on glycaemic outcomes including fasting plasma glucose, fasting plasma insulin, haemoglobin A1c, and homeostatic model assessment of ...\n3. For instance, according to a research by Łagowska et al., the administration of synbiotics and probiotics has been observed to have a beneficial effect on reducing blood glucose levels, HOMA-IR, and insulin levels in pregnant women diagnosed with gestational diabetes mellitus [ 51 ].\n4. Our data clearly suggest that probiotics could be a supplementary therapeutic approach in type 2 diabetes mellitus patients to improve dyslipidemia and to promote better metabolic control.\n5. Probiotics have been reported to have a positive impact on the metabolic control of patients with type 2 diabetes. We aimed to systematically evaluate the effects of probiotics on cardiometabolic parameters in type 2 diabetes based on randomized controlled studies.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": " What kind of probiotics were used in these clinical trials?",
               "answer": "The specific types of probiotics used in the clinical trials are not explicitly mentioned in the provided evidence snippet. However, one example given is \"Lactobacillus,\" which is a common genus of probiotics. For a more comprehensive understanding of the specific strains or types of probiotics used in the various studies, additional information from the",
               "rationale": "1. Close analysis of the clinical studies with probiotics showed that only 32% of the studies were registered before the first participants were included. The majority of studies were registered prior to completion of the study. However, some studies were registered as late as 900 days after completion of the study.\n2. A meta-analysis of 21 clinical trials in which prenatal and postnatal women were given probiotics showed that they are effective in preventing but not treating atopic dermatitis . The results of another meta-analysis showed the preventive effect of probiotics on the development of eczema, but the effectiveness of the use of probiotics for other ...\n3. Table 1. Fields of study in which there are meta-analysis concerning the evaluation of efficacy of the consumption of probiotics. The purpose of this study was to perform a review considering all the meta-analysis published in the literature on the effectiveness of the use of probiotics in clinical practice.\n4. These include IBD 86, type 2 diabetes mellitus ... these were relatively short-term studies over ... A. et al. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus ...\n5. Over 1,000 clinical studies with probiotics, registered at ClinicalTrials.gov and/or the International Clinical Trials Registry Platform (ICTRP) of the World Health Organization, have addressed over 700 different diseases and conditions. The average size of a clinical trial with probiotics (74 participants) is comparable to the overall average ...",
               "predicate": null
            }
         ],
         "row": 4,
         "id": 263273433671962475
      },
      {
         "claim": "In everyday life, when breathing with an FFP2 mask or ordinary mouth-nose protection, do you get as much oxygen as without a mask?",
         "label": 0,
         "prediction": 1,
         "rationale": " When wearing an FFP2 mask, oxygen intake during everyday breathing is affected, as there is evidence indicating that oxygen uptake (VO2) decreases and the breathing reserve is significantly impacted. This suggests that the use of FFP2 masks can influence respiratory parameters during daily activities and potentially during physical exercise. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": " Does wearing an FFP2 mask or ordinary mouth-nose protection affect the oxygen intake during everyday breathing?  (I adjusted the wording to make it a question about the effect of wearing a mask, as the original claim seems to be a statement about oxygen availability rather than a question.)",
               "answer": "Yes, wearing an FFP2 mask affects oxygen intake during everyday breathing. The evidence indicates that oxygen uptake (VO2) was reduced when wearing FFP2 masks, and the breathing reserve was significantly impacted. This suggests that the use of such masks can influence respiratory parameters and may lead to decreased oxygen intake during physical activity",
               "rationale": "1. For breathing reserve, the difference was statistically significant, when wearing FFP2. With each type of mask, oxygen uptake (VO 2) was reduced and Ttot was longer with increasing load levels ...\n2. Background While assumed to protect against coronavirus transmission, face masks may have effects on respiratory-haemodynamic parameters. Within this pilot study, we investigated immediate and progressive effects of FFP2 and surgical masks on exhaled breath constituents and physiological attributes in 30 adults at rest. Methods We continuously monitored exhaled breath profiles within mask ...\n3. W hen the COVID-19 pandemic took off in 2020, so too did questions over the effectiveness of wearing a face mask to prevent the spread of the virus. Now, four years later, what does the science say?\n4. In areas that have many people with COVID-19 in the hospital, the CDC recommends wearing a face mask indoors in public. The CDC says that you should wear the most protective mask that you'll wear regularly, fits well and is comfortable. Respirators such as nonsurgical N95s give the most protection. KN95s and medical masks provide the next ...\n5. The average dead space volume during breathing in adults is approximately 150-180 mL and is significantly increased when wearing a mask covering the mouth and nose . With an N95 mask, for example, the dead space volume of approximately 98-168 mL was determined in an experimental study . This corresponds to a mask-related dead space increase ...",
               "predicate": null
            }
         ],
         "row": 5,
         "id": 104047804082408720
      },
      {
         "claim": "Can a bioresonance device like \"Bioscan\" or \"Vieva Vital Analyser\" measure mineral and vitamin deficiencies or detect health problems?",
         "label": 2,
         "prediction": 0,
         "rationale": " According to the evidence, it is not possible to provide specific information about the health problems or mineral and vitamin deficiencies that a \"Bioscan\" or \"Vieva Vital Analyzer\" can measure.  According to the evidence snippet indicating \"No results found,\" there is no scientific evidence supporting the claim that a \"Bioscan\" or \"Vieva Vital Analyzer\" can measure specific health problems or mineral and vitamin deficiencies. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": " What specific health problems or mineral and vitamin deficiencies can a \"Bioscan\" or \"Vieva Vital Analyzer\" measure?",
               "answer": "The provided evidence snippet indicates that there are no results found regarding the specific health problems or mineral and vitamin deficiencies that a \"Bioscan\" or \"Vieva Vital Analyzer\" can measure. Therefore, I cannot provide a definitive answer based on the available information.",
               "rationale": "No results found.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": " Is there any scientific evidence supporting the claim that a \"Bioscan\" or \"Vieva Vital Analyzer\" can measure specific health problems or mineral and vitamin deficiencies?",
               "answer": "Based on the provided evidence snippet stating \"No results found,\" there appears to be no scientific evidence supporting the claim that a \"Bioscan\" or \"Vieva Vital Analyzer\" can measure specific health problems or mineral and vitamin deficiencies.",
               "rationale": "No results found.",
               "predicate": null
            }
         ],
         "row": 6,
         "id": 506404647379872258
      },
      {
         "claim": "Does arthroscopy (joint endoscopy) help with osteoarthritis of the knee joint?",
         "label": 2,
         "prediction": 1,
         "rationale": " Arthroscopy plays a role in treating osteoarthritis of the knee joint by enabling the identification and treatment of local lesions while preserving the joint, which may involve lavage, partial meniscectomy, or chondroplasty.  In osteoarthritis of the knee joint, arthroscopy can involve the removal of damaged cartilage, as minimally invasive arthroscopic procedures are used to take out articular cartilage that has broken down due to overuse or injury, causing pain and swelling. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": " What is the role of arthroscopy in treating osteoarthritis of the knee joint?",
               "answer": "The role of arthroscopy in treating osteoarthritis of the knee joint includes the identification and treatment of local lesions while preserving the joint. Arthroscopic procedures for osteoarthritis may involve lavage (washing out the joint), partial meniscectomy (removal of part of the meniscus), chondroplasty (smoothing of the",
               "rationale": "1. Drilling of osteochondral lesions. For many years arthroscopy was commonly performed to treat knee osteoarthritis with the process including lavage of the joint and debridement of roughened surfaces with removal of loose debris. Meniscal tears were often resected or repaired as part of this process.\n2. The knee was the model joint for arthroscopy; both diagnostic and therapeutic applications of arthroscopic surgery debuted in the knee. By the mid-1980s, with evidence of several advantages of arthroscopic over open surgical procedures, arthroscopy became the preferred method of treatment when indicated [ 1 , 5 ].\n3. Knee arthroscopy is a very common minimally invasive surgical procedure. Minimally invasive procedures require smaller incisions (cuts) than traditional surgery. The incisions are about the size of a keyhole. To treat injuries or structural problems, your healthcare provider inserts tiny tools through another incision.\n4. In 1990, Burks1) described that the role of arthroscopy in the treatment of osteoarthritis of the knee is to allow identification and treatment of a local lesion while preserving the joint, which is accepted by most authors. Arthroscopic procedures for osteoarthritis of the knee include lavage, partial meniscectomy, chondroplasty, synovectomy ...\n5. Arthroscopy (ahr-THROS-skuh-pee) is a procedure for diagnosing and treating joint problems. A surgeon inserts a narrow tube attached to a fiber-optic video camera through a small incision — about the size of a buttonhole. The view inside your joint is transmitted to a high-definition video monitor.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": " Does arthroscopy involve the removal of damaged cartilage in osteoarthritis of the knee joint?",
               "answer": "Yes, arthroscopy can involve the removal of damaged cartilage in osteoarthritis of the knee joint. The evidence indicates that minimally invasive arthroscopic procedures are used to remove articular cartilage, which can break down due to overuse or injury, leading to pain and swelling.",
               "rationale": "1. Knee arthroscopy is a very common minimally invasive surgical procedure. Minimally invasive procedures require smaller incisions (cuts) than traditional surgery. The incisions are about the size of a keyhole. To treat injuries or structural problems, your healthcare provider inserts tiny tools through another incision.\n2. Minimally invasive arthroscopic procedure to remove articular cartilage in the knee. Articular cartilage is a firm rubbery tissue that covers the ends of bones. It provides a smooth gliding surface for joints and acts as a cushion between bones. Cartilage can break down due to overuse or injury. This can lead to pain and swelling and problems ...\n3. Arthroscopic procedures that involve the removal of damaged structures such as cartilage typically require less rehabilitation to return to normal activities. More involved surgeries that involve the repair of damaged structures, such as a repair of the anterior cruciate ligament (ACL) , posterior cruciate ligament (PCL) , or meniscus , can ...\n4. Arthroscopy (ahr-THROS-skuh-pee) is a procedure for diagnosing and treating joint problems. A surgeon inserts a narrow tube attached to a fiber-optic video camera through a small incision — about the size of a buttonhole. The view inside your joint is transmitted to a high-definition video monitor.\n5. In either case, an arthroscopy is a useful way for doctors to confirm the source of knee pain and treat the problem. Arthroscopic surgery can diagnose and treat knee injuries, including: torn ...",
               "predicate": null
            }
         ],
         "row": 7,
         "id": 772871890645054808
      },
      {
         "claim": "Can regular intake of cranberry juice or cranberry extract prevent recurrent cystitis in women?",
         "label": 0,
         "prediction": 1,
         "rationale": " According to research, cranberry juice or extract may have a limited impact on decreasing recurrent cystitis in women, as some studies have shown uncertain evidence with a subgroup analysis suggesting no significant reduction in urinary tract infections through cranberry consumption.  Some studies suggest that cranberry consumption may help decrease the occurrence of recurrent cystitis in women, as indicated by a study where women who consumed 41.1 mg of cranberry proanthocyanidin in a beverage had fewer clinical UTI episodes.  According to the evidence, there is no specific recommended dosage provided for cranberry juice or extract to prevent recurrent cystitis in women, but both cranberry juice and tablets have been found to reduce the occurrence of UTIs, particularly in women with a history of recurrent UTIs. For precise dosage recommendations, one should refer to clinical guidelines.  Women, especially those with a history of recurrent urinary tract infections (UTIs), may benefit from regular cranberry juice or extract intake as a preventative measure for recurrent cystitis.  The active ingredient in cranberry juice or extract believed to potentially decrease the occurrence of recurrent cystitis in women is proanthocyanidins (PAC) containing Type A linkages. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": " What does research suggest about the impact of cranberry juice or extract on recurrent cystitis in women?",
               "answer": "Research suggests that cranberry juice or extract may have a non-significant impact on reducing recurrent cystitis (urinary tract infections) in women. While some studies have evaluated the effectiveness of cranberry products in this context, the evidence remains uncertain, with a subgroup analysis indicating that cranberry consumption did not lead to a statistically significant reduction in",
               "rationale": "1. Recently, cranberry juice was reported to reduce UTIs in an animal model, 20 and numerous in vitro experiments reported antimicrobial or antiadhesive properties of the phenolic components of cranberry products against E. coli. 21. Interestingly, the authors were also able to show that the use of cranberry extract reduces the use of antibiotics.\n2. Abstract. Cranberry ( Vaccinium macrocarpon) is a distinctive source of polyphenols as flavonoids and phenolic acids that has been described to display beneficial effects against urinary tract infections (UTIs), the second most common type of infections worldwide. UTIs can lead to significant morbidity, especially in healthy females due to high ...\n3. Cranberry products—including juice or capsules—reduced the risk of symptomatic, confirmed urinary tract infections (UTIs) in several groups, according to results published in the Cochrane Database of Systematic Reviews.. The results suggested that consuming cranberry products reduced UTI risk in children by 54%, in people susceptible to UTIs after a medical intervention such as radiation ...\n4. A subgroup analysis of women with recurrent UTI found that cranberry consumption resulted in a non-significant reduction in recurrent UTIs . Whilst many studies have evaluated the effectiveness of cranberry extract in reducing recurrent UTI, few have assessed effects on symptoms of acute UTIs . The aim of this systematic review was therefore to ...\n5. Two studies, one in women with recurrent UTIs (Sengupta 2011) and one in pregnant women , compared different amounts of cranberry either as juice or tablets. It is uncertain whether the risk for clinical UTIs differs between groups as the certainty of the evidence is very low ( Analysis 5.1 : (2 studies, 169 participants): RR 1.02, 95% CI 0.27 ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": " What do some studies report about the relationship between cranberry consumption and the occurrence of recurrent cystitis in women?",
               "answer": "Some studies report that cranberry consumption may help lower the occurrence of recurrent cystitis (urinary tract infections, or UTIs) in women. For instance, one study indicated that the consumption of 41.1 mg of cranberry proanthocyanidin in a beverage reduced the number of clinical UTI episodes in women with",
               "rationale": "1. The consumption of 41.1 mg cranberry proanthocyanidin in a beverage lowered the number of clinical UTI episodes in women with a recent history of UTI . Vostalova et al. showed that the study tested whether whole cranberry fruit powder (proanthocyanidin content 0.56%) could prevent recurrent UTI in 182 women with two or more UTI episodes.\n2. In the first randomized double-blind study examining whether cranberry juice consumption could prevent the recurrence of UTI, women in a nursing home consumed 300 mL/d of artificially sweetened cranberry juice for 6 mo . After 1 mo, the prevalence of bacteriuria with pyuria was significantly lowered for the women who had consumed cranberry juice.\n3. This approach allowed for a broader understanding of the patterns and associations within bacterial communities that were more consistent across the study population. Consumption of cranberry ...\n4. There are additional human studies reporting positive results for cranberry consumption on the prevention of UTI in women which have some limitations. One hundred and fifty women were divided into three groups. Among those randomized to consume 50 mL of cranberry-lingonberry juice for 6 months, compared to a no-intervention control (there\n5. This study aims to update the evidence and clarify whether cranberry possesses lipid-lowering and hypoglycemic properties in humans. PubMed, Web of Science, and Scopus were searched to identify relevant articles published up to December 2023. In total, 3145 publications were reviewed and 16 of them were included for qualitative synthesis and meta-analysis. Stata 15.0 and Review Manager 5.4 ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": " How much cranberry juice or extract is recommended for preventing recurrent cystitis in women?",
               "answer": "The evidence snippets do not provide a specific recommended dosage of cranberry juice or extract for preventing recurrent cystitis in women. However, they mention that cranberry juice and tablets can reduce the occurrence of UTIs, particularly in women with a history of recurrent UTIs. For precise recommendations, it is advisable to refer to clinical guidelines or",
               "rationale": "1. Benefits of preventing UTI with cranberry products: 1 in 16 women with recurrent UTIs: 1 in 8 children: 1 in 9 people with susceptibility to UTI due to a bladder intervention: Harms of preventing ...\n2. A significant reduction was observed (>50% decrease) in the proportion of women experiencing symptomatic UTI during the 12-month follow-up period in the cranberry juice and cranberry tablet groups ...\n3. Pregnant women: Cranberry juice ‐ Group 2: 240 mL cranberry drink at breakfast, placebo juice at other meals ... Type A PAC in cranberry extract: 9.1 mg/g: Sengupta 2011: 2011: 57: India: Medical clinic ... this review (Jepson 2008) we concluded that 'There was some evidence to show that cranberries (juice and capsules) can prevent recurrent ...\n4. One 2013 analysis of 13 different trials concluded that cranberry juice and tablets did reduce the occurrence of UTIs compared to placebo in women with recurrent UTIs. But another review found ...\n5. Purpose Our objective was to assess the efficacy of a high dose cranberry proanthocyanidin extract for the prevention of recurrent urinary tract infection. Material and methods We recruited 145 healthy, adult women with a history of recurrent urinary tract infection, defined as ≥ 2 in the past 6 months or ≥ 3 in the past 12 months in this randomized, controlled, double-blind clinical trial ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": " Who are the primary target groups that may benefit from regular cranberry juice or extract intake in preventing recurrent cystitis?",
               "answer": "The primary target groups that may benefit from regular cranberry juice or extract intake in preventing recurrent cystitis are women, particularly those with recurrent urinary tract infections (UTIs).",
               "rationale": "1. However, Jepson et al. suggested that the benefit of cranberry-containing products might be limited in some subgroups, mostly for women with recurrent UTI, and might be absent in most population groups. We concluded that supplementing cranberry may be beneficial in preventing and treating UTIs in susceptible populations, particularly for women ...\n2. An ex vivo study examining human urine following cranberry juice cocktail consumption suggests that twice-daily dosages of cranberries (36 mg of PAC) might offer additional protection during a 24 h period (25,28). Recommended doses of dried, concentrated juice extract range from 600 to >1,200 mg/day divided into two or three daily doses. It is ...\n3. Cranberries (particularly in the form of cranberry juice) have been used widely for several decades to prevent and treat UTIs. Cranberries comprise nearly 90% water, but also contain various organic substances such as quinic acid, malic acid and citric acid as well as glucose and fructose.\n4. For decades, cranberry products have been used in the treatment and prevention of UTIs. Cranberries' mechanism of action uses proanthocyanidins, which inhibit the adherence of p-fimbriated ...\n5. One study reported that there were \"overall no marked differences\" between the cranberry juice and placebo liquid groups, in terms of urinary and ... (DUAB®) in preventing low urinary tract infection recurrence in women complaining of recurrent cystitis. Urol Int, 103 (2019), pp. 41 ... Highly standardized cranberry extract supplementation ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": " What is the active ingredient in cranberry juice or extract that may potentially reduce the occurrence of recurrent cystitis in women?",
               "answer": "The active ingredient in cranberry juice or extract that may potentially reduce the occurrence of recurrent cystitis in women is proanthocyanidins (PAC) with Type A linkages.",
               "rationale": "1. Abstract. Cranberry ( Vaccinium macrocarpon) is a distinctive source of polyphenols as flavonoids and phenolic acids that has been described to display beneficial effects against urinary tract infections (UTIs), the second most common type of infections worldwide. UTIs can lead to significant morbidity, especially in healthy females due to high ...\n2. The active ingredient may be proanthocyanidins (PAC) with Type A linkages. PAC with Type A linkages is thought to prevent Escherichia coli (E. coli) from binding to the uroepithelial lining , therefore preventing E. coli from causing and sustaining a UTI. Trials have assessed the use of cranberry products to prevent recurrent UTIs.\n3. CRANBERRIES. Cranberry is a term derived from the contraction of \"crane berry.\" This name is derived from the nickname of the bilberry flower, which, when it withers, is similar in appearance to the head and neck of the sand crane, a bird that often feeds on the berries of this plant ().The cranberry is part of the Ericaceae family and naturally grows in acidic swamps full of peat moss in ...\n4. Policy. One of the most widely held beliefs about UTIs is that drinking cranberry juice (or taking cranberry supplements) can prevent and get rid of them. \"There is an active ingredient in ...\n5. Cranberries contain proanthocyanidins (PACs), which inhibit the adherence of p‐fimbriated Escherichia coli to the urothelial cells lining the bladder. Cranberry products have been used widely for several decades to prevent urinary tract infections (UTIs). This is the fifth update of a review first published in 1998 and updated in 2003, 2004 ...",
               "predicate": null
            }
         ],
         "row": 8,
         "id": 120891112715574841
      }
   ]
}